BWX Technologies, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Jim Cramer Weighs In on BWX Technologies After 27% Pullback

Capacity expansion Defense contract AI-generated analysis

πŸ“‰ Jim Cramer notes a 27% stock pullback over three months driven by an August quarter that came in somewhat weaker than expected.

πŸ›‘οΈ BWXT holds a virtual monopoly on naval nuclear reactors, manufacturing propulsion systems for Virginia-class attack submarines and Columbia-class ballistic missile submarines.

πŸ“ˆ Total backlog doubled to $8.4 billion, representing roughly nine quarters of contracted run rate as of the September 29 Investor Day.

πŸ’° The company projects full-year 2026 revenue of $3.8 billion, with approximately $3.7 billion (98%) generated directly from core nuclear activities.

πŸ”„ BWXT is selling a majority stake in its non-core medical isotope unit for up to $800 million while retaining a 20% interest.

πŸ—οΈ Proceeds from the sale are being reallocated into high-return nuclear manufacturing assets, including a Precision Components Group acquisition.

🎯 Updated 2030 financial roadmap targets annual revenues of $5.5 billion to $6 billion on low double-digit compound organic growth.

πŸ’Ή Adjusted EBITDA margins are projected to expand from 17.5% to approximately 20% by the end of the decade.

πŸ“‰ The stock trades at around a 36x TTM price-to-earnings multiple and 27x forward earnings following the valuation reset.

⚠️ Margin volatility within Government Operations remains a constant, structural reality that frequently limits upside surprises.

πŸ”§ Realizing margin expansion depends heavily on scaling unproven commercial SMR production lines while navigating supply chain bottlenecks.

πŸ“‰ Insider selling has continued, including share sales by CEO Rex Geveden under a Rule 10b5-1 trading plan.

🏦 Hedge fund holders expanded to 65 in the second quarter compared to 61 in the preceding quarter according to Insider Monkey data.

πŸ“Š Alkeon Capital Management was the top hedge fund holder in Q2 with a position of 2.02 million shares.

πŸ“‰ Short interest remains low at 4.42% of the public float as of the latest reporting period.

Bullish Signals
  • BWX Technologies holds a virtual monopoly in manufacturing naval nuclear reactors and fuel components for the U.S. Navy, providing a sovereign defense moat that anchors long-term operational stability.
  • Total backlog doubled to $8.4 billion, representing roughly nine quarters of contracted run rate as highlighted at the September 29 Investor Day.
  • The company projects full-year 2026 revenue of $3.8 billion, with approximately $3.7 billion (98%) generated directly from core nuclear activities.
  • BWXT is selling a majority stake in its non-core medical isotope unit for up to $800 million while retaining a 20% interest to reallocate capital into high-return assets.
  • Proceeds are being invested in a Precision Components Group acquisition and a 500,000-square-foot footprint expansion to support nuclear manufacturing.
  • Updated 2030 financial roadmap targets annual revenues of $5.5 billion to $6 billion on low double-digit compound organic growth.
  • Adjusted EBITDA margins are projected to expand from 17.5% to approximately 20% by the end of the decade.
  • Second-quarter results reported non-GAAP diluted earnings per share of $1.07 on 18% revenue growth to $901.6 million.
Risk Factors
  • The stock has endured a severe pullback from its 52-week highs of over $241 down into the $130-$140 range, driven by a broader industrial selloff and a weaker-than-expected August quarter.
  • Margin volatility within Government Operations remains a constant, structural reality of defense contracting that frequently limits upside surprises.
  • Realizing projected margin expansion depends heavily on scaling unproven commercial SMR production lines while navigating ongoing supply chain bottlenecks for military-grade specialty alloys.
  • Insider selling has continued, including share sales by CEO Rex Geveden under a Rule 10b5-1 trading plan.
Full Analysis
Jim Cramer addressed the recent 27% pullback in BWX Technologies (BWXT) stock during a Mad Money segment, attributing the decline to a weaker-than-expected August quarter rather than structural flaws. Despite the volatility, Cramer highlighted the company's bullish long-term targets for 2030 presented at its September 29 Investor Day, noting that most of the recent quarterly results were positive aside from one or two lines. BWX Technologies maintains a virtual monopoly on manufacturing naval nuclear reactors and fuel components for the U.S. Navy, providing a sovereign defense moat with total backlog doubling to $8.4 billion. The company projects full-year 2026 revenue of $3.8 billion, with approximately 98% generated from core nuclear activities supporting Virginia-class submarines, Columbia-class ballistic missile submarines, and Gerald R. Ford-class aircraft carriers. To capture accelerating global demand, BWXT is executing a strategic pivot by selling a majority stake in its non-core medical isotope unit for up to $800 million while retaining a 20% interest. Proceeds are being reallocated into high-return nuclear manufacturing assets, including a Precision Components Group acquisition and a 500,000-square-foot footprint expansion, supporting updated 2030 financial roadmap targets of $5.5 billion to $6 billion in annual revenue. While the stock trades at around 36x TTM earnings, analysts note structural margin volatility in Government Operations and supply chain bottlenecks for military-grade alloys as primary headwinds. However, hedge fund holders expanded to 65 in the second quarter, with Alkeon Capital Management leading holdings, suggesting institutional confidence in BWXT's ability to balance sovereign defense obligations with high-margin nuclear infrastructure expansion.